{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:32:35Z","timestamp":1791822755606,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,2]],"date-time":"2019-04-02T00:00:00Z","timestamp":1554163200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbadis.2017.08.033","type":"journal-article","created":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T17:45:18Z","timestamp":1504547118000},"page":"1498-1506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"PB","title":["Drug-induced bile duct injury"],"prefix":"10.1016","volume":"1864","author":[{"given":"Michele","family":"Visentin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Lenggenhager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibo","family":"Gai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd A.","family":"Kullak-Ublick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2017.08.033_bb0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1055\/s-2003-42641","article-title":"Acute liver failure in the United States","volume":"23","author":"Lee","year":"2003","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2016-313369","article-title":"Drug-induced liver injury: recent advances in diagnosis and risk assessment","author":"Kullak-Ublick","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0015","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.2174\/092986709788803097","article-title":"Current concepts of mechanisms in drug-induced hepatotoxicity","volume":"16","author":"Russmann","year":"2009","journal-title":"Curr. Med. Chem."},{"issue":"4","key":"10.1016\/j.bbadis.2017.08.033_bb0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/hep.28967","article-title":"Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements","volume":"65","author":"Bonkovsky","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1089-3261(05)70114-8","article-title":"Mechanisms of cholestasis","volume":"4","author":"Kullak-Ublick","year":"2000","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0030","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5604\/16652681.1171749","article-title":"Drug-induced fatty liver disease: an overview of pathogenesis and management","volume":"14","author":"Satapathy","year":"2015","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/j.2040-4603.2013.tb00495.x","article-title":"Physiology of cholangiocytes","volume":"3","author":"Tabibian","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","article-title":"The Cholangiopathies","volume":"90","author":"Lazaridis","year":"2015","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1055\/s-2007-991516","article-title":"Cholangiocyte injury and ductopenic syndromes","volume":"27","author":"Xia","year":"2007","journal-title":"Semin. Liver Dis."},{"issue":"Suppl. 1","key":"10.1016\/j.bbadis.2017.08.033_bb0050","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0168-8278(97)82330-6","article-title":"Vanishing bile duct syndrome in drug-induced liver disease","volume":"26","author":"Desmet","year":"1997","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0055","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jhep.2012.10.011","article-title":"The dynamic biliary epithelia: molecules, pathways, and disease","volume":"58","author":"O'Hara","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0060","first-page":"1232","article-title":"Drug and toxin-induced bile duct disorders","volume":"15","author":"Geubel","year":"2000","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0065","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1053\/j.gastro.2013.02.006","article-title":"Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland","volume":"144","author":"Bjornsson","year":"2013","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.bbadis.2017.08.033_bb0070","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/hep.29040","article-title":"Idiosyncratic drug-induced liver injury associated with bile duct loss and vanishing bile duct syndrome: rare but has severe consequences","volume":"65","author":"Bjornsson","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0075","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1046\/j.1469-1809.2003.00046.x","article-title":"A reassessment of genetic diversity in Icelanders: strong evidence from multiple loci for relative homogeneity caused by genetic drift","volume":"67","author":"Helgason","year":"2003","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0080","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting","volume":"11","author":"Benichou","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0085","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/0895-4356(93)90101-6","article-title":"Causality assessment of adverse reactions to drugs\u2013I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries","volume":"46","author":"Danan","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0090","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/0895-4356(93)90102-7","article-title":"Causality assessment of adverse reactions to drugs\u2013II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge","volume":"46","author":"Benichou","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0095","article-title":"RUCAM in drug and herb induced liver injury: the update","volume":"17","author":"Danan","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0100","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1172\/JCI113355","article-title":"Biliary physiology in rats with bile ductular cell hyperplasia. Evidence for a secretory function of proliferated bile ductules","volume":"81","author":"Alpini","year":"1988","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0105","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"N. United States drug induced liver injury, features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0110","first-page":"1456","article-title":"Drug-induced vanishing bile duct syndrome: response to ursodiol","volume":"91","author":"O'Brien","year":"1996","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0115","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/hep.1840200610","article-title":"Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis","volume":"20","author":"Moradpour","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0120","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-208117","article-title":"Vanishing bile duct syndrome in the context of concurrent temozolomide for glioblastoma","volume":"2014","author":"Mason","year":"2014","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0125","doi-asserted-by":"crossref","first-page":"6087","DOI":"10.3748\/wjg.v13.i45.6087","article-title":"Mycophenolate mofetil for drug-induced vanishing bile duct syndrome","volume":"13","author":"Jakab","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0130","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1097\/MPG.0b013e3182a95951","article-title":"Nonsteroidal anti-inflammatory drug-induced vanishing bile duct syndrome treated with plasmapheresis","volume":"57","author":"Kawasaki","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0135","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1440-1754.2008.01291.x","article-title":"A favorable response to steroid therapy in a child with drug-associated acute vanishing bile duct syndrome and skin disorder","volume":"44","author":"Tajiri","year":"2008","journal-title":"J. Paediatr. Child Health"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0140","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/ACI.0000000000000078","article-title":"The importance of hapten-protein complex formation in the development of drug allergy","volume":"14","author":"Faulkner","year":"2014","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0145","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","article-title":"Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept","volume":"2","author":"Pichler","year":"2002","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0150","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acs.chemrestox.6b00333","article-title":"New approaches to investigate drug-induced hypersensitivity","volume":"30","author":"Ogese","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0155","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3109\/03602532.2011.645579","article-title":"Role of immune reactions in drug-induced liver injury (DILI)","volume":"44","author":"Ju","year":"2012","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0160","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1124\/pr.113.007450","article-title":"Idiosyncratic adverse drug reactions: current concepts","volume":"65","author":"Uetrecht","year":"2013","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0165","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/toxsci\/kfv077","article-title":"Activation of flucloxacillin-specific CD8+ T-cells with the potential to promote hepatocyte cytotoxicity in a mouse model","volume":"146","author":"Nattrass","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0170","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.168.6.3079","article-title":"Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis","volume":"168","author":"Akiba","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0175","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1084\/jem.189.5.779","article-title":"Cytotoxicity is mandatory for CD8(+) T cell-mediated contact hypersensitivity","volume":"189","author":"Kehren","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000029938","article-title":"New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse models","volume":"13","author":"Traidl","year":"2000","journal-title":"Skin Pharmacol. Appl. Ski. Physiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0185","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1398-9995.2009.02307.x","article-title":"CD8+ T cells mediate skin allergy to amoxicillin in a mouse model","volume":"65","author":"Rozieres","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2016.08.001","article-title":"Drug metabolism in the liver","volume":"21","author":"Almazroo","year":"2017","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/00002018-200730040-00001","article-title":"Drug-induced liver injury","volume":"30","author":"Abboud","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0200","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/0006-2952(91)90180-D","article-title":"Drug metabolizing enzyme activities in rat liver epithelial cell lines, hepatocytes and bile duct cells","volume":"41","author":"Schrenk","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0168-8278(88)80029-1","article-title":"Isolation and characterization of biliary epithelial cells from normal rat liver","volume":"6","author":"Parola","year":"1988","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0210","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0168-8278(90)90143-F","article-title":"Biochemical studies on bile duct epithelial cells isolated from rat liver","volume":"10","author":"Parola","year":"1990","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0215","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1002\/hep.510300619","article-title":"Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium","volume":"30","author":"Lakehal","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0220","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/hep.22370","article-title":"Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury","volume":"48","author":"Lucena","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0225","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00001.2006","article-title":"Mechanisms of liver injury. III. Role of glutathione redox status in liver injury","volume":"291","author":"Han","year":"2006","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0230","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/tx0002435","article-title":"Indirect cytotoxicity of flucloxacillin toward human biliary epithelium via metabolite formation in hepatocytes","volume":"14","author":"Lakehal","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0235","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/prca.200800222","article-title":"Characterisation of flucloxacillin and 5-hydroxymethyl flucloxacillin haptenated HSA in vitro and in vivo","volume":"3","author":"Jenkins","year":"2009","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0240","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.tox.2005.07.015","article-title":"Immunochemical detection of flucloxacillin adduct formation in livers of treated rats","volume":"216","author":"Carey","year":"2005","journal-title":"Toxicology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0245","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1124\/mol.62.3.628","article-title":"Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation","volume":"62","author":"Naisbitt","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0250","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/dmd.107.016501","article-title":"CYP3A4-Mediated carbamazepine (CBZ) metabolism: formation of a covalent CBZ-CYP3A4 adduct and alteration of the enzyme kinetic profile","volume":"36","author":"Kang","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0255","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.105.006866","article-title":"Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine","volume":"33","author":"Bu","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0260","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jprot.2012.09.030","article-title":"Protein haptenation by amoxicillin: high resolution mass spectrometry analysis and identification of target proteins in serum","volume":"77","author":"Ariza","year":"2012","journal-title":"J. Proteome"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0265","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1021\/acs.chemrestox.6b00253","article-title":"Amoxicillin and clavulanate form chemically and immunologically distinct multiple haptenic structures in patients","volume":"29","author":"Meng","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0270","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0022-3565(24)36867-3","article-title":"The relationship between the disposition and immunogenicity of sulfamethoxazole in the rat","volume":"282","author":"Gill","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0275","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1124\/dmd.107.019562","article-title":"Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine","volume":"36","author":"Pearce","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0280","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1021\/tx0002029","article-title":"Identification of a reactive metabolite of terbinafine: insights into terbinafine-induced hepatotoxicity","volume":"14","author":"Iverson","year":"2001","journal-title":"Chem. Res. Toxicol."},{"issue":"1987","key":"10.1016\/j.bbadis.2017.08.033_bb0285","first-page":"1","article-title":"Clinical pharmacokinetics of sulfonamides and their metabolites: an encyclopedia","volume":"37","author":"Vree","year":"1971","journal-title":"Antibiot. Chemother."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0290","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-9556(25)08967-6","article-title":"Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity","volume":"19","author":"Cribb","year":"1991","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0295","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/clpt.1992.57","article-title":"Sulfamethoxazole is metabolized to the hydroxylamine in humans","volume":"51","author":"Cribb","year":"1992","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0300","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1038\/sj.bjp.0702453","article-title":"Cellular disposition of sulphamethoxazole and its metabolites: implications for hypersensitivity","volume":"126","author":"Naisbitt","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0305","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1159\/000371864","article-title":"The cholangiocyte glycocalyx stabilizes the \u2018Biliary HCO3 Umbrella\u2019: an integrated line of defense against toxic bile acids","volume":"33","author":"Maillette de Buy Wenniger","year":"2015","journal-title":"Dig. Dis."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0310","doi-asserted-by":"crossref","first-page":"G1077","DOI":"10.1152\/ajpgi.00227.2012","article-title":"Advances in cholangiocyte immunobiology","volume":"303","author":"Syal","year":"2012","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0315","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.autrev.2015.07.006","article-title":"Gene\/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors","volume":"14","author":"Gianchecchi","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0320","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2016.12.016","article-title":"D.-I.L.I.N.I. international drug-induced liver injury consortium, C. international serious adverse events, association of liver injury from specific drugs, or groups of drugs, with polymorphisms in hla and other genes in a genome-wide association study","volume":"152","author":"Nicoletti","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0325","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1136\/gut.22.12.985","article-title":"Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody","volume":"22","author":"Barbatis","year":"1981","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0330","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.jpedsurg.2004.07.010","article-title":"The aberrant expression of HLA-DR in intrahepatic bile ducts in patients with biliary atresia: an immunohistochemistry and immune electron microscopy study","volume":"39","author":"Feng","year":"2004","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0335","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/00007890-198511000-00007","article-title":"Induction of DR\/IA antigens in human liver allografts. An immunocytochemical and clinicopathologic analysis of twenty failed grafts","volume":"40","author":"Demetris","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0340","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/hep.510240317","article-title":"Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells","volume":"24","author":"Leon","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0345","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1478-3231.2008.01921.x","article-title":"Cholangiocytes as immune modulators in rotavirus-induced murine biliary atresia","volume":"29","author":"Barnes","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0350","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/hep.22011","article-title":"Coculture of human liver macrophages and cholangiocytes leads to CD40-dependent apoptosis and cytokine secretion","volume":"47","author":"Alabraba","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0355","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.27840","article-title":"The biliary epithelium presents antigens to and activates natural killer T cells","volume":"62","author":"Schrumpf","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0360","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/PL00000869","article-title":"CD1d and natural T cells: how their properties jump-start the immune system","volume":"58","author":"Joyce","year":"2001","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0365","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S0016-5085(99)70404-X","article-title":"HLA association of amoxicillin-clavulanate\u2013induced hepatitis","volume":"117","author":"Hautekeete","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0370","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/hep.20215","article-title":"HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease","volume":"39","author":"Andrade","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0375","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/ng.379","article-title":"HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin","volume":"41","author":"Daly","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0380","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/hep.27912","article-title":"Characterization of amoxicillin- and clavulanic acid-specific T cells in patients with amoxicillin-clavulanate-induced liver injury","volume":"62","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0385","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/gut.33.3.368","article-title":"Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases","volume":"33","author":"Larrey","year":"1992","journal-title":"Gut"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0390","doi-asserted-by":"crossref","first-page":"4956","DOI":"10.4049\/jimmunol.1202949","article-title":"HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin","volume":"190","author":"Wuillemin","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0395","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0400","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/sj.bjp.0703845","article-title":"Influence of reduced glutathione on the proliferative response of sulfamethoxazole-specific and sulfamethoxazole-metabolite-specific human CD4+ T-cells","volume":"132","author":"Burkhart","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0405","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/hep.26077","article-title":"Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury","volume":"57","author":"Monshi","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0410","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.3747\/co.21.1592","article-title":"Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era","volume":"21","author":"Ko","year":"2014","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0415","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1001\/archsurg.1984.01390200054013","article-title":"Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity","volume":"119","author":"Daly","year":"1984","journal-title":"Arch. Surg."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0420","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1245\/s10434-011-2102-8","article-title":"Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors","volume":"19","author":"Ito","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0425","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/1097-0142(19920115)69:2<327::AID-CNCR2820690209>3.0.CO;2-U","article-title":"A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer","volume":"69","author":"Kemeny","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0430","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/08941930490524363","article-title":"The effect of scolicidal agents on liver and biliary tree (experimental study)","volume":"17","author":"Sahin","year":"2004","journal-title":"J. Investig. Surg."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0435","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ajg.2010.485","article-title":"Ketamine-induced cholangiopathy: a case report","volume":"106","author":"Seto","year":"2011","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0440","first-page":"e52","article-title":"Cholestasis and biliary dilatation associated with chronic ketamine abuse: a case series","volume":"52","author":"Lo","year":"2011","journal-title":"Singap. Med. J."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0445","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.26459","article-title":"Ketamine abuse, biliary tract disease, and secondary sclerosing cholangitis","volume":"58","author":"Turkish","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0450","first-page":"53","article-title":"Dilated common bile ducts mimicking choledochal cysts in ketamine abusers","volume":"15","author":"Wong","year":"2009","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0455","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.dld.2015.03.002","article-title":"Secondary sclerosing cholangitis in patients with drug-induced liver injury","volume":"47","author":"Gudnason","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0460","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840090209","article-title":"Floxuridine-induced sclerosing cholangitis: an ischemic cholangiopathy","volume":"9","author":"Ludwig","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0465","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/SLA.0b013e3181d35983","article-title":"Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases","volume":"251","author":"Goere","year":"2010","journal-title":"Ann. Surg."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0470","doi-asserted-by":"crossref","first-page":"4086","DOI":"10.1002\/cncr.25277","article-title":"A phase 1 study of hepatic arterial infusion of oxaliplatin in combination with systemic 5-fluorouracil, leucovorin, and bevacizumab in patients with advanced solid tumors metastatic to the liver","volume":"116","author":"Tsimberidou","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0475","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/annonc\/mdh022","article-title":"Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver","volume":"15","author":"van Riel","year":"2004","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0480","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00280-010-1266-4","article-title":"Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement","volume":"66","author":"Tsimberidou","year":"2010","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0485","first-page":"561","article-title":"The influence of 5-fluorouracil on the endothelium in small arteries. An electron microscopic study in rabbits","volume":"9","author":"Cwikiel","year":"1995","journal-title":"Scanning Microsc."},{"key":"10.1016\/j.bbadis.2017.08.033_bb0490","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/molecules14010053","article-title":"Decreased oxygen transfer capacity of erythrocytes as a cause of 5-fluorouracil related ischemia","volume":"14","author":"Spasojevic","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.bbadis.2017.08.033_bb0495","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303150?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443917303150?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T04:47:26Z","timestamp":1760417246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443917303150"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0925443917303150"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.033","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced bile duct injury","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2017.08.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}